Gilead Virus Therapy Remdesivir Gains Approval From FDA
The U.S. Food and Drug Administration approved Gilead Sciences Inc.’s antiviral therapy remdesivir on Thursday, granting broad clearance for the coronavirus treatment.
Related Articles
The Urgent Need for Telemedicine 2.0
Today’s anemic version of telemedicine is no more innovative than a call from the doctor 50 years ago.
When AI images were “mind-blowing”—early users recall the first days of DALL-E 2
How a group of friends found themselves at the center of a fierce debate about the future of art.
First law protecting consumers’ brainwaves signed by Colorado governor
Colorado Governor Jared Polis on Wednesday signed into law the first measure passed in the U.S. that aims to protect the data found in a…
Anthropic CEO Says That by Next Year, AI Models Could Be Able to “Replicate and Survive in the Wild”
As AI seems to grow more powerful every day, the CEO of Anthropic is saying that soon, it might be self-sustaining and self-replicating.
LLMs and the Specter of the Cognitive Black Hole
Is a “human escape velocity” even possible anymore?
AI-Generated Draft Replies Integrated Into Health Records and Physicians’ Electronic Communication
This quality improvement study investigates the association between generative artificial intelligence–drafted replies for patient messages and physician time spent on answering messages and the length…
Platform versus Platformization: George Kurtz on why CrowdStrike is winning the platform battle
Customers and the industry believe that having the data, having it organized, and using the data not only for AI training but for other outcomes,…
Driving Innovation at Humanity’s Tipping Point | NOSTALAB
NostaLab is a health technology think tank recognized globally for having an inspired vision of transformation.